Mind Medicine (MindMed) Inc.

NasdaqGS:MNMD Stock Report

Market Cap: US$525.1m

Mind Medicine (MindMed) Balance Sheet Health

Financial Health criteria checks 5/6

Mind Medicine (MindMed) has a total shareholder equity of $262.2M and total debt of $24.3M, which brings its debt-to-equity ratio to 9.3%. Its total assets and total liabilities are $319.8M and $57.6M respectively.

Key information

9.3%

Debt to equity ratio

US$24.31m

Debt

Interest coverage ration/a
CashUS$295.28m
EquityUS$262.19m
Total liabilitiesUS$57.58m
Total assetsUS$319.77m

Recent financial health updates

Recent updates

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate

Nov 04

Psychedelic Stocks: Focus On Their Cash

Aug 15

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

Jun 05

Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data

Apr 04

Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts

Feb 02

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

May 23
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

Feb 07
We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics

Oct 19

MindMed announces proposed public offering of common shares

Sep 27

MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances

Sep 20

MindMed regains compliance with Nasdaq's minimum bid price listing requirement

Sep 14

MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value

Sep 04

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Aug 26
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder

Aug 24

MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps

Aug 18

Financial Position Analysis

Short Term Liabilities: MNMD's short term assets ($299.4M) exceed its short term liabilities ($33.3M).

Long Term Liabilities: MNMD's short term assets ($299.4M) exceed its long term liabilities ($24.3M).


Debt to Equity History and Analysis

Debt Level: MNMD has more cash than its total debt.

Reducing Debt: Insufficient data to determine if MNMD's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MNMD has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: MNMD has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 27.5% each year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mind Medicine (MindMed) Inc. is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Sumant Satchidanand KulkarniCanaccord Genuity
Tania Armstrong-WhitworthCanaccord Genuity